Chronic low back pain (CLBP) is a major public health concern that will continue to grow with the expected aging of the population.
This webinar will introduce the participants to Apos, a non-invasive foot-worn medical device for the management of chronic lower limb and lower back pain.
It will present the outcomes of a recently published randomised controlled trial (RCT) which investigated the outcomes of the home-based biomechanical intervention (Apos) compared to standard care in patients with chronic lower back pain. The study was conducted following 3 retrospective studies that suggested positive outcomes of the intervention on the proposed cohort.
This RCT investigated the clinical outcomes in 162 patients with Chronic Low Back Pain (CLBP). Participants were randomised in a 2:1 ratio and assessed over a52-week period using the Numeric Rating Scale (NRS) as the primary outcome, alongside secondary measures including the Oswestry Disability Index (ODI)and gait parameters.
The trial was approved by the Albert Einstein College of Medicine IRB committee (ClinicalTrials.gov Identifier: NCT03167671) and conducted in the United States.
This webinar will introduce the participants to Apos, a non-invasive foot-worn medical device for the management of chronic lower limb and lower back pain.
It will present the outcomes of a recently published randomised controlled trial (RCT) which investigated the outcomes of the home-based biomechanical intervention (Apos) compared to standard care in patients with chronic lower back pain. The study was conducted following 3 retrospective studies that suggested positive outcomes of the intervention on the proposed cohort.
This RCT investigated the clinical outcomes in 162 patients with Chronic Low Back Pain (CLBP). Participants were randomised in a 2:1 ratio and assessed over a52-week period using the Numeric Rating Scale (NRS) as the primary outcome, alongside secondary measures including the Oswestry Disability Index (ODI)and gait parameters.
The trial was approved by the Albert Einstein College of Medicine IRB committee (ClinicalTrials.gov Identifier: NCT03167671) and conducted in the United States.